The business case for preconception care: Methods and issues

Maternal and Child Health Journal

Volumn 10, Issue 1, 2006, Pages 93-99

  Grosse, Scott D ^a   Sotnikov, Sergey V ^b   Leatherman, Sheila ^c   Curtis, Michele ^d  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b National Center for Health Marketing   (United States)

^c IL   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Birth defects; Cost benefit analysis; Diabetes in pregnancy; Economic evaluation; Prenatal care

Indexed keywords

FOLIC ACID;

AMBULATORY CARE; ARTICLE; BARIATRIC SURGERY; CHILD HOSPITALIZATION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HIGH RISK PREGNANCY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INVESTMENT; LOW BIRTH WEIGHT; MANAGED CARE ORGANIZATION; MATERNAL CARE; MATERNAL DIABETES MELLITUS; OBESITY; PREGNANCY OUTCOME; PREMATURITY; PRENATAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; REIMBURSEMENT; SPINA BIFIDA; VITAMIN SUPPLEMENTATION;

EID: 33748709835     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-006-0101-3     Document Type: Article

References (42)

1. Petrini J, Damus K, Russell R, Poschman K, Davidoff MJ, Mattison D. Contribution of birth defects to infant mortality in the United States. Teratology 2002; 66: S3-6.
2. Centers for Disease Control and Prevention. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment - United States, 2003. MMWR 2004; 53: 57-9.
3. Leatherman S, Berwick D, Iles D, Lewin LS, Davidoff F, Nolan T, et al. The business case for quality: Case studies and an analysis. Health Aff 2003; 22: 17-30.
4. Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. Pharmacoeconomics 2001; 19: 609-21.
5. Haddix AC, Teutsch SM, Corso PS, editors. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. 2nd ed. London: Oxford University Press; 2003.
6. Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, et al. Priorities among recommended clinical preventive services. Am J Prev Med 2001; 21: 1-9.
7. Lu MC, Lin YG, Prietto NM, Garite TJ. Elimination of public funding of prenatal care for undocumented immigrants in California: A cost/benefit analysis. Am J Obstet Gynecol 2000; 182: 233-9.
8. Goetzel RZ, Juday TR, Ozminkowski RJ. A systematic review of return on investment (ROI) studies of corporate health and productivity management initiatives. AWHP's Worksite Health 1999; Summer: 12-21.
9. Finkelstein EA, Brown DS. A cost-benefit simulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care 2005; 11: 641-6.
10. Warner KE, Smith RJ, Smith DG, Fries BE. Health and economic implications of a work-site smoking-cessation program: A simulation analysis. J Occup Environ Med 1996; 38: 981-92.
11. Warner KE, Mendez D, Smith DG. The financial implications of coverage of smoking cessation treatment by managed care organizations. Inquiry 2004; 41: 57-69.
12. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 2004; 46: 398-412.
13. Aldana SG, Merrill RM, Price K, Hardy A, Hager R. Financial impact of a comprehensive multisite workplace health promotion program. Prev Med 2005; 40: 131-7.
14. Korenbrot CC. Risk reduction in pregnancies of low-income women: comprehensive prenatal care through the OB Access Project. Mobius 1984; 4: 34-43.
15. Gorsky RD, Colby JP Jr. The cost effectiveness of prenatal care in reducing low birth weight in New Hampshire. Health Serv Res 1989; 24: 583-98.
16. Schramm WF. Weighing costs and benefits of adequate prenatal care for 12,023 births in Missouri's Medicaid program, 1988. Public Health Rep 1992; 107: 647-52.
17. Howell EM. The impact of the Medicaid expansions for pregnant women: A synthesis of the evidence. Med Care Res Rev 2001; 58: 3-30.
18. Huntington J, Connell FA. For every dollar spent - the cost-savings argument for prenatal care. N Engl J Med 1994; 331: 1303-7.
19. Farnham PG, Gorsky RD. Costs to business for an HIV-infected worker. Inquiry 1994; 31: 76-88.
20. Chollet DJ, Newman JF Jr, Sumner AT. The cost of poor birth outcomes in employer-sponsored health plans. Med Care 1996; 34: 1219-34.
21. Grosse SD, Waitzman NJ, Romano PS, Mulinare J. Re-evaluating the benefits of folic acid fortification in the United States: Economic analysis, regulation, and public health. Am J Public Health. 2005; in press.
22. Goetzel RZ, Ozminkowski RJ, Villagra VG, Duffy J. A review of the return on investment in disease management. Health Care Financ Rev 2005; 26 (4): 1-19.
23. Aldana SG. Financial impact of health promotion programs: A comprehensive review of the literature. Am J Health Promot 2001; 15: 296-320.
24. Kilpatrick KE, Lohr KN, Leatherman S, Pink G, Buckel JM, Legarde C, et al. The insufficiency of evidence to establish the business case for quality. Int J Qual Health Care 2005; 17: 347-55.
25. Homer C. Child Health Business Case Working Group. Exploring the business case for improving the quality of health care for children. Health Aff 2004; 23: 159-66.
26. Hawkins MR. The impact of a high-risk disease management program on perinatal outcomes in a managed care organization. Case Manager 2005; 16: 59-63.
27. Sackett K, Pope RK, Erdley WS. Demonstrating a positive return on investment for a prenatal program at a managed care organization. An economic analysis. J Perinat Neonatal Nurs 2004; 18: 117-27.
28. Stankaitis JA, Brill HR, Walker DM. Reduction in neonatal intensive care unit admission rates in a Medicaid managed care program. Am J Manag Care 2005; 11: 166-72.
29. Diehl-Svrjcek BC, Richardson R. Decreasing NICU costs in the managed care arena: The positive impact of collaborative high-risk OB and NICU disease management programs. Lippincotts Case Manag 2005; 10: 159-66.
30. Kelly AE, Haddix AC, Scanlon KS, Helmick CG, Mulinare J. Cost-effectiveness of strategies to prevent neural tube defects. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996. p. 313-48.
31. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus. Q J Med 2001; 94: 435-44.
32. Jovanovic L, Nakai Y. Successful pregnancy in women with type 1 diabetes: From preconception through postpartum care. Endocrinol Metab Clin North Am 2006; 35: 79-97.
33. Willhoite MB, Bennert HW Jr, Palomaki GE, Zaremba MM, Herman WH, Williams JR, et al. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 1993; 16: 450-5.
34. Loeken MR. Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am J Med Genet C Semin Med Genet 2005; 135: 77-87.
35. Elixhauser A, Weschler JM, Kitzmiller JL, Marks JS, Bennert HW Jr, Coustan DR, et al. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993; 16: 1146-57.
36. Scheffler RM, Feuchtbaum LB, Phibbs CS. Prevention: The cost-effectiveness of the California Diabetes and Pregnancy Program. Am J Public Health 1992; 82: 168-75.
37. Herman WH, Janz NK, Becker MP, Charron-Prochownik D. Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs. J Reprod Med 1999; 44: 33-8.
38. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care 2004; 27: S76-8.
39. American College of Obstetricians and Gynecologists. Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol 2005; 105: 675-85.
40. Kim C, Ferrara A, McEwen LN, Marrero DG, Gerzoff RB, Herman WH; TRIAD Study Group. Preconception care in managed care: The Translating Research Into Action for Diabetes study. Am J Obstet Gynecol 2005; 192: 227-32.
41. Prue C, Lyon Daniel K. Marketing: Planning before conceiving preconception care. Matern Child Health J. In press.
42. Russell LB, Suh DC, Safford MA. Time requirements for diabetes self-management: Too much for many? J Fam Pract 2005; 54: 52-6.